dpp 4 inhibitor and glp 1 receptor agonist combination GLP-1 versus DPP-4 kidney and cardiovascular outcomes in clinical practice in type-2 diabetes GLP-1 receptor agonists or DPP-4
Description
The trial randomized and dosed 94 people for the first 12 weeks of study
Identification of a prolonged action molecular GLP-1R agonist for the treatment of femoral defects
Saxenda (liraglutide) Saxenda was approved by the FDA in 2014 for chronic weight management in adults
The intent behind this particular paper isnt to shame parents, Pratt said
It doesnt just make you feel anxious, but it actually impacts your hormones and metabolism
But if there are other outcomes that your patient is concerned about, then you have to consider the effect size for those other outcomes, Polley said
